文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

温度轨迹亚表型与脓毒症患者免疫反应相关

Temperature Trajectory Subphenotypes Correlate With Immune Responses in Patients With Sepsis.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在脓毒症休克与金黄色葡萄球菌菌血症两个队列中,四种体温轨迹亚表型与一致的细胞因子谱相关,提示可用体温在床旁进行免疫表型分型。

该前瞻性观察研究在大规模学术医疗中心2013至2019年间纳入两个感染患者队列:ICU脓毒症休克患者120例和金黄色葡萄球菌菌血症住院患者88例。根据感染发生后最初72小时的体温测量,将患者分为四种既往验证过的体温亚表型:高热缓慢消退型、高热快速消退型、正常体温型和低体温型。控制队列和细胞因子测量时间后,高热缓慢消退型和高热快速消退型相比低体温型具有更高的G-CSF、CCL2和白细胞介素-10水平(p < 0.05);与高热缓慢消退型不同,高热快速消退型在24小时内多种细胞因子水平显著下降,包括白细胞介素-1RA、白细胞介素-6、白细胞介素-8、G-CSF和M-CSF(p < 0.001)。作者认为这些亚表型可能有助于床旁识别脓毒症患者的细胞因子谱。

要点

  • 在脓毒症休克(120例)和金黄色葡萄球菌菌血症(88例)两个队列中,患者均可被分为四种体温轨迹亚表型:高热缓慢消退型、高热快速消退型、正常体温型、低体温型。
  • 控制队列和测量时间后,高热缓慢消退型和高热快速消退型相比低体温型具有更高的G-CSF、CCL2和白细胞介素-10水平(p < 0.05)。
  • 高热快速消退型在24小时内白细胞介素-1RA、白细胞介素-6、白细胞介素-8、G-CSF和M-CSF水平显著下降(p < 0.001),而高热缓慢消退型无此表现。
  • 体温轨迹亚表型在两个不同感染队列中与一致的细胞因子谱相关,作者认为可能有助于床旁识别脓毒症患者的细胞因子谱。

适用人群与场景

  • 两个感染患者队列:1)ICU脓毒症休克患者(队列1,n=120);2)金黄色葡萄球菌菌血症住院患者(队列2,n=88)。
  • 研究在大规模学术医疗中心2013至2019年间进行。

诊断标准与关键阈值

  • 根据感染发生后最初72小时的体温测量,将患者分为四种既往验证过的体温亚表型:高热缓慢消退型(队列1 n=19;队列2 n=13)、高热快速消退型(队列1 n=18;队列2 n=24)、正常体温型(队列1 n=54;队列2 n=31)、低体温型(队列1 n=29;队列2 n=20)。

研究设计与关键结果

  • 研究类型:前瞻性观察研究;两个队列:ICU脓毒症休克患者120例和金黄色葡萄球菌菌血症住院患者88例。
  • 控制队列和细胞因子测量时间后,高热缓慢消退型和高热快速消退型相比低体温型具有更高的G-CSF、CCL2和白细胞介素-10水平(p < 0.05)。
  • 与高热缓慢消退型不同,高热快速消退型在24小时内白细胞介素-1RA、白细胞介素-6、白细胞介素-8、G-CSF和M-CSF水平显著下降(p < 0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,体温轨迹亚表型可能有助于床旁识别脓毒症患者的细胞因子谱。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We recently found that distinct body temperature trajectories of infected patients correlated with survival. Understanding the relationship between the temperature trajectories and the host immune response to infection could allow us to immunophenotype patients at the bedside using temperature. The objective was to identify whether temperature trajectories have consistent associations with specific cytokine responses in two distinct cohorts of infected patients.

DESIGN: Prospective observational study.

SETTING: Large academic medical center between 2013 and 2019.

SUBJECTS: Two cohorts of infected patients: 1) patients in the ICU with septic shock and 2) hospitalized patients with Staphylococcus aureus bacteremia.

INTERVENTIONS: Clinical data (including body temperature) and plasma cytokine concentrations were measured. Patients were classified into four temperature trajectory subphenotypes using their temperature measurements in the first 72 hours from the onset of infection. Log-transformed cytokine levels were standardized to the mean and compared with the subphenotypes in both cohorts.

MEASUREMENTS AND MAIN RESULTS: The cohorts consisted of 120 patients with septic shock (cohort 1) and 88 patients with S. aureus bacteremia (cohort 2). Patients from both cohorts were classified into one of four previously validated temperature subphenotypes: "hyperthermic, slow resolvers" (n = 19 cohort 1; n = 13 cohort 2), "hyperthermic, fast resolvers" (n = 18 C1; n = 24 C2), "normothermic" (n = 54 C1; n = 31 C2), and "hypothermic" (n = 29 C1; n = 20 C2). Both "hyperthermic, slow resolvers" and "hyperthermic, fast resolvers" had high levels of G-CSF, CCL2, and interleukin-10 compared with the "hypothermic" group when controlling for cohort and timing of cytokine measurement (p < 0.05). In contrast to the "hyperthermic, slow resolvers," the "hyperthermic, fast resolvers" showed significant decreases in the levels of several cytokines over a 24-hour period, including interleukin-1RA, interleukin-6, interleukin-8, G-CSF, and M-CSF (p < 0.001).

CONCLUSIONS: Temperature trajectory subphenotypes are associated with consistent cytokine profiles in two distinct cohorts of infected patients. These subphenotypes could play a role in the bedside identification of cytokine profiles in patients with sepsis.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bhavani SV, Wolfe KS, Hrusch CL, et al. Temperature Trajectory Subphenotypes Correlate With Immune Responses in Patients With Sepsis. Crit Care Med. 2020. PMID: 32947475. doi:10.1097/CCM.0000000000004610

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。